RS49517B - PEPTID p277-ANALOZI I FARMACEUTSKI PREPARATI KOJI GA SADRZE - Google Patents

PEPTID p277-ANALOZI I FARMACEUTSKI PREPARATI KOJI GA SADRZE

Info

Publication number
RS49517B
RS49517B YU78795A YU78795A RS49517B RS 49517 B RS49517 B RS 49517B YU 78795 A YU78795 A YU 78795A YU 78795 A YU78795 A YU 78795A RS 49517 B RS49517 B RS 49517B
Authority
RS
Serbia
Prior art keywords
peptide
cells
val
cell
izdm
Prior art date
Application number
YU78795A
Other languages
English (en)
Serbian (sr)
Inventor
Irun R. Cohen
Dana Elias
Matityahu Fridkin
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26322965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS49517(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL11209494A external-priority patent/IL112094A0/xx
Priority claimed from IL11446095A external-priority patent/IL114460A0/xx
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of YU78795A publication Critical patent/YU78795A/sh
Publication of RS49517B publication Critical patent/RS49517B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
YU78795A 1994-12-21 1995-12-21 PEPTID p277-ANALOZI I FARMACEUTSKI PREPARATI KOJI GA SADRZE RS49517B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL11209494A IL112094A0 (en) 1994-12-21 1994-12-21 Novel peptides and pharmaceutical compositions comprising them
IL11446095A IL114460A0 (en) 1995-07-05 1995-07-05 Peptide p277 analogs and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes

Publications (2)

Publication Number Publication Date
YU78795A YU78795A (sh) 1998-05-15
RS49517B true RS49517B (sr) 2006-10-27

Family

ID=26322965

Family Applications (1)

Application Number Title Priority Date Filing Date
YU78795A RS49517B (sr) 1994-12-21 1995-12-21 PEPTID p277-ANALOZI I FARMACEUTSKI PREPARATI KOJI GA SADRZE

Country Status (31)

Country Link
EP (1) EP0820303B1 (cg-RX-API-DMAC7.html)
JP (2) JP3420245B2 (cg-RX-API-DMAC7.html)
KR (1) KR100400480B1 (cg-RX-API-DMAC7.html)
CN (1) CN1233417C (cg-RX-API-DMAC7.html)
AR (1) AR002949A1 (cg-RX-API-DMAC7.html)
AT (1) ATE242005T1 (cg-RX-API-DMAC7.html)
AU (1) AU707835B2 (cg-RX-API-DMAC7.html)
BR (1) BR9510102A (cg-RX-API-DMAC7.html)
CA (1) CA2208274C (cg-RX-API-DMAC7.html)
CZ (1) CZ293784B6 (cg-RX-API-DMAC7.html)
DE (2) DE69531004T2 (cg-RX-API-DMAC7.html)
DK (1) DK0820303T3 (cg-RX-API-DMAC7.html)
ES (1) ES2201137T3 (cg-RX-API-DMAC7.html)
FI (1) FI118373B (cg-RX-API-DMAC7.html)
HR (1) HRP950612B1 (cg-RX-API-DMAC7.html)
HU (1) HU224160B1 (cg-RX-API-DMAC7.html)
IL (1) IL116499A0 (cg-RX-API-DMAC7.html)
IS (1) IS1966B (cg-RX-API-DMAC7.html)
MX (1) MX9704738A (cg-RX-API-DMAC7.html)
NO (1) NO317350B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ301440A (cg-RX-API-DMAC7.html)
PL (1) PL184145B1 (cg-RX-API-DMAC7.html)
PT (1) PT820303E (cg-RX-API-DMAC7.html)
RO (1) RO116777B1 (cg-RX-API-DMAC7.html)
RS (1) RS49517B (cg-RX-API-DMAC7.html)
SI (1) SI0820303T1 (cg-RX-API-DMAC7.html)
TR (1) TR199501630A2 (cg-RX-API-DMAC7.html)
TW (1) TW496872B (cg-RX-API-DMAC7.html)
UA (1) UA42040C2 (cg-RX-API-DMAC7.html)
UY (1) UY24130A1 (cg-RX-API-DMAC7.html)
WO (1) WO1996019236A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488933B2 (en) 1995-07-05 2002-12-03 Yeda Research And Development Co. Ltd. Preparations for the treatment of T cell mediated diseases
WO1997043649A1 (en) * 1996-05-14 1997-11-20 Winnacker Ernst Ludwig CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrP?sc¿
JP2005503320A (ja) * 2000-08-25 2005-02-03 イエダ・リサーチ・アンド・デベロツプメント・カンパニー・リミテツド CpG−含有ポリヌクレオチドで自己免疫疾患を処置または防止する方法
IL140233A0 (en) * 2000-12-11 2002-02-10 Peptor Ltd Backbone cyclized analogs of heat shock proteins
EP2157101B1 (en) 2002-01-31 2014-09-24 Andromeda Bio Tech Ltd. HSP peptides and analogs for modulation of immune responses via antigen presenting cells
WO2005072056A2 (en) 2004-01-28 2005-08-11 Develogen Israel Ltd. Hsp therapy in conjunction with a low antigenicity diet
DE102004043750A1 (de) * 2004-09-10 2006-03-30 Sanofi-Aventis Deutschland Gmbh Formulierungen des Peptids p277 oder dessen Varianten mit optimierter Stabilität
RU2282453C2 (ru) * 2004-12-14 2006-08-27 Александр Борисович Смолянинов Способ терапии больных сахарным диабетом ii типа
CN100352502C (zh) * 2004-12-29 2007-12-05 中国药科大学 能通过免疫防治ⅰ型糖尿病的重组蛋白和重组基因
US8691772B2 (en) 2005-01-04 2014-04-08 Yeda Research And Development Co. Ltd. HSP60, HSP60 peptides and T cell vaccines for immunomodulation
EP1858545A2 (en) 2005-03-04 2007-11-28 Curedm Inc. Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions
EA013821B1 (ru) 2005-05-25 2010-08-30 Кьюрдм, Инк. Проостровковые пептиды человека, их производные и аналоги и способы их применения
JP4283812B2 (ja) * 2006-01-06 2009-06-24 財団法人工業技術研究院 重症筋無力症の診断方法およびそのキット
US8785400B2 (en) 2006-11-22 2014-07-22 Curedm Group Holdings, Llc Methods and compositions relating to islet cell neogenesis
EA201000399A1 (ru) 2007-08-30 2011-02-28 Кьюрдм, Инк. Композиции и способы использования проостровковых пептидов и их аналогов
CU23701A1 (es) * 2008-12-29 2011-09-21 Ct Ingenieria Genetica Biotech Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i
CN104244967A (zh) 2012-03-01 2014-12-24 耶达研究与发展有限公司 用于抑制和治疗非自身免疫性糖尿病的Hsp60衍生肽和肽类似物
WO2013128453A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Regeneration of islet beta cells by hsp60 derived peptides
CN104418948B (zh) * 2013-09-10 2019-08-16 深圳翰宇药业股份有限公司 一种制备多肽药物的方法
CN104650209B (zh) * 2013-11-19 2018-04-06 深圳翰宇药业股份有限公司 多肽药物DiaPep277 的合成方法
CN104650244B (zh) * 2015-01-21 2017-12-08 中国药科大学 一种具有降血糖兼调脂作用的表位组合肽及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus

Also Published As

Publication number Publication date
EP0820303A4 (cg-RX-API-DMAC7.html) 1998-03-11
DK0820303T3 (da) 2003-10-06
CN1233417C (zh) 2005-12-28
NZ301440A (en) 2000-01-28
AR002949A1 (es) 1998-05-27
KR100400480B1 (ko) 2003-12-31
CA2208274A1 (en) 1996-06-27
CZ190897A3 (en) 1997-11-12
NO972849D0 (no) 1997-06-19
AU707835B2 (en) 1999-07-22
SI0820303T1 (en) 2003-10-31
CN1175214A (zh) 1998-03-04
UA42040C2 (uk) 2001-10-15
CZ293784B6 (cs) 2004-07-14
FI972669A0 (fi) 1997-06-19
TR199501630A2 (tr) 1996-07-21
JP3554319B2 (ja) 2004-08-18
NO972849L (no) 1997-08-13
TW496872B (en) 2002-08-01
HRP950612A2 (en) 1997-10-31
DE69531004D1 (de) 2003-07-10
DE69531004T2 (de) 2004-02-05
IS1966B (is) 2004-12-15
WO1996019236A1 (en) 1996-06-27
JP2004026797A (ja) 2004-01-29
BR9510102A (pt) 1997-11-25
NO317350B1 (no) 2004-10-18
HU224160B1 (hu) 2005-06-28
RO116777B1 (ro) 2001-06-29
JPH10511649A (ja) 1998-11-10
FI118373B (fi) 2007-10-31
PL321091A1 (en) 1997-11-24
DE820303T1 (de) 1999-05-20
ATE242005T1 (de) 2003-06-15
YU78795A (sh) 1998-05-15
PL184145B1 (pl) 2002-09-30
IL116499A0 (en) 1996-03-31
UY24130A1 (es) 1996-06-11
ES2201137T3 (es) 2004-03-16
EP0820303B1 (en) 2003-06-04
JP3420245B2 (ja) 2003-06-23
FI972669L (fi) 1997-08-15
HUT78092A (hu) 1999-09-28
EP0820303A1 (en) 1998-01-28
CA2208274C (en) 2005-12-06
IS4510A (is) 1997-06-19
PT820303E (pt) 2003-10-31
AU4686696A (en) 1996-07-10
HRP950612B1 (en) 2003-12-31
MX9704738A (es) 1997-10-31

Similar Documents

Publication Publication Date Title
RS49517B (sr) PEPTID p277-ANALOZI I FARMACEUTSKI PREPARATI KOJI GA SADRZE
EP0417271B1 (en) Diagnosis and treatment of insulin dependent diabetes mellitus
Lennon et al. Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs.
US5780034A (en) Diagnosis and treatment of insulin dependent diabetes mellitus using heat shock protein determinents
DE69634438T2 (de) Von humanem hitzeschockprotein 60 hergeleitete peptide zur behandlung von diabetis, entsprechende zusammensetzungen, verfahren und kits
JP4256474B2 (ja) 宿主vs移植片反応の重篤度をHSP60自己免疫性をダウンレギュレーションすることにより低下させる方法
JP2607751B2 (ja) 自己免疫性ブドウ膜網膜炎の治療予防薬
US6180103B1 (en) Peptide p277 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
DE69637130T2 (de) Immunoreaktive und immunotherapeutische moleküle welche in individuen mit insulin-abhängiger diabetes mellitus interagieren
CZ298A3 (cs) Přípravky a způsoby ošetřování nemocí zprostředkovanými T buňkami
MXPA98000190A (en) Preparations and methods for the treatment of medium diseases by cellula
Takahashi et al. Prevention of type I diabetes with lymphotoxin in BB rats
US20030190323A1 (en) Preparations and methods for the treatment of T cell mediated diseases
Liversidge et al. Antigen processing and presentation in the eye: a review
RU2159250C2 (ru) АНАЛОГИ ПЕПТИДА p277 И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ ДЛЯ ЛЕЧЕНИЯ И ДИАГНОСТИКИ ДИАБЕТА
HK1253094A1 (zh) 多肽组合物
IL111361A (en) Polypeptides derived from hHSP65 and pharmaceutical compositions comprising them for prevention or treatment of insulin dependent diabetes mellitus (IDDM)